The Treasurers of Connecticut and Rhode Island, members of Investors for Opioid and Pharmaceutical Accountability, are urging AmerisourceBergen (ABC) shareholders to vote "AGAINST" the company's "say on pay" proposal  which appears as Item #3 (“Advisory Vote to Approve the Compensation of our Named Executive Officers") on the company's 2021 proxy statement, at the March 11th meeting of shareholders. The proposal reflects payouts for certain executives that are significantly above target, including $14.3 million for CEO Steven Collis, despite a $6.6 billion legal charge made in connection with the proposed settlement of opioid-related claims – triggering the company’s largest-ever loss. Incentive awards are not entitlements, and their payout in the face of such huge charges reflects poorly on ABC's broader culture and accountability.

These concerns lead us to urge fellow shareholders to oppose the ratification of the company's executive compensation arrangements, Item #3 on the company's 2021 proxy ballot.  Click here to read the exempt solicitation.